SGLT2 Inhibitors and HF Outcomes Across Patient Populations SGLT2 Inhibitors and HF Outcomes Across Patient Populations
This brief paper summarizes recent trials on the efficacy of SGLT2 inhibitors in heart failure patients with diabetes, chronic kidney disease, HFrEF, HFpEF, and worsening HF.European Heart Journal
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
More News: Cardiology | Chronic Kidney Disease | Diabetes | Endocrinology | Health | Heart | Heart Failure | SGLT2 Inhibitors | Urology & Nephrology